Latest News and Press Releases
Want to stay updated on the latest news?
-
EPALINGES, Switzerland, Jan. 19, 2010 (GLOBE NEWSWIRE) -- Mymetics Corporation, a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today that following...
-
EPALINGES, Switzerland, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX), a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today...
-
EPALINGES, Switzerland, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Jacques-Francois Martin, newly appointed President and CEO of Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX), announced today the...
-
NYON, Switzerland, June 26, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), today announced that its Board of Directors has named Jacques-Francois Martin as Chairman of...
-
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and...
-
NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its...
-
This Acquisition Advances Mymetics' Corporate Strategy to Expand Its Vaccine Portfolio and Enhances Mymetics' Implementation of the Virosome Delivery Technology NYON, Switzerland, March 9, 2009...
-
NYON, Switzerland, March 9, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (www.mymetics.com) (OTCBB:MYMX) announced today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil...
-
Mymetics Corporation verkündet Erfolg ihres Präventivimpfstoffes gegen HIV/AIDS und Start der europäischen Phase 1 von menschlichen klinischen Studien NYON, Schweiz, 6. Feb. 2009 (GLOBE NEWSWIRE)...
-
NYON, Switzerland, Feb. 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX), announced today that on February 11, in Montreal, at the 16th world Conference on Retroviruses...